Our Mission
Advancing Cancer Diagnostics, Improving Lives
Our Vision
From translational research to patient treatment, we envision a world where comprehensive insights enrich cancer diagnosis and offer reassurance to all patients.
News & Events
Danaher and Leica Biosystems Announce Diagnostic Development and Commercialization Partnership to Scale Precision Medicine
Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powered diagnostics
Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
Leica Biosystems, a global leader in anatomic pathology solutions, and Advanced Cell Diagnostics (ACD), a Bio-Techne brand and a global leader in spatial biology, today announced an expansion of their longstanding partnership to offer innovative spatial multiomic solutions.
Leica Biosystems and CellCarta Partner to Accelerate Companion Diagnostics Development in China
Leica Biosystems, a global leader in anatomic pathology, today announced a strategic partnership with CellCarta, a globally recognized Contract Research Organization laboratory serving the biopharmaceutical industry.
Leica Biosystems at a Glance
150+ Years of Innovation
| 2012 - Present | New Era of Science & Technology |
| 2005 - 2011 | Global Expansion Accelerates |
| 1989 - 2004 | Structuring for Comprehensive Workflow |
| 1930 - 1988 | Novel Products Drive Company Growth |
| 1900 - 1930 | Microtomy Technology Advances Amidst Wartime Realities |
| 1872 - 1899 | The Creation of the Microtome and the Early Years of R. Jung GMBH |
About Danaher
Leica Biosystems is proud to be part of Danaher. Danaher’s science and technology leadership puts Leica Biosystems’ solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.